New ovarian cancer findings small but significant step toward early detection

“(POCRC researchers) have taken a small but potentially significant step toward early detection of ovarian cancer, finding that protein "biomarkers" released by tumors show up in women's bloodstreams years before symptoms appear, though not necessarily early enough to save lives.”

Read More in the Seattle Time


Dr. Beth Karlan discusses what's new in ovarian cancer screening

“Dr. Beth Karlan gives an overview of what's new in ovarian cancer screening at ASCO 2011. Topics mentioned include the POCRC Novel Markers Trial and recent results from the Prostate, Lung, Colon, and Ovary (PLCO) Trial.”

Read More



Muneesh Tewari, POCRC Investigator, discusses cancer in general in this video.





“Of women diagnosed with invasive breast cancer, 30 percent will develop a recurrence within five years. Eighty percent of women treated for ovarian cancer relapse after the first treatment. To prevent cancer recurrence, the UW Tumor Vaccine Group, directed by Dr. Mary L. "Nora" Disis, associate professor of medicine in the Division of Oncology, researches how to boost the immune system in cancer patients. Disis, who is also an associate member of the Fred Hutchinson Cancer Research Center, has had success with a cancer vaccine.”

Read More on the UW website

Nora Disis to be editor-in-chief of new JAMA journal

Dr. Mary L. "Nora" Disis, a cancer researcher and professor of medicine in oncology at the University of Washington, has been named editor-in-chief of JAMA Network’s new journal, JAMA Oncology, which will launch next year.”

Read More in the Seattle Times